- Report
- November 2023
- 178 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- November 2023
- 190 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- November 2023
- 78 Pages
Germany
From €3105EUR$3,500USD£2,710GBP
- Report
- November 2023
- 78 Pages
France
From €3105EUR$3,500USD£2,710GBP
- Report
- March 2023
- 116 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- December 2022
- 115 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5642EUR$6,360USD£4,925GBP
€7053EUR$7,950USD£6,157GBP
- Report
- February 2024
- 200 Pages
Global
From €5323EUR$6,000USD£4,646GBP
€6654EUR$7,500USD£5,808GBP
- Report
- May 2024
- 279 Pages
Global
From €4436EUR$5,000USD£3,872GBP
- Report
- January 2024
- 200 Pages
Global
From €4436EUR$5,000USD£3,872GBP
- Report
- June 2021
Global
From €3549EUR$4,000USD£3,098GBP
- Report
- June 2024
- 182 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- February 2024
- 184 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- November 2023
- 120 Pages
Asia Pacific
From €3549EUR$4,000USD£3,098GBP
- Report
- November 2023
- 77 Pages
France
From €3105EUR$3,500USD£2,710GBP
- Report
- January 2024
- 120 Pages
Global
From €5642EUR$6,360USD£4,925GBP
€7053EUR$7,950USD£6,157GBP
- Report
- May 2023
- 450 Pages
Global
From €3549EUR$4,000USD£3,098GBP
€4436EUR$5,000USD£3,872GBP
- Report
- April 2023
- 399 Pages
Global
From €6743EUR$7,600USD£5,886GBP
€8428EUR$9,500USD£7,357GBP
- Report
- October 2024
- 200 Pages
Global
From €3327EUR$3,750USD£2,904GBP
- Report
- May 2024
- 200 Pages
Global
From €3682EUR$4,150USD£3,214GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more